By Steven Ayre, MD
Summary: An exciting overview of an innovative new cancer therapy based on the fact that cancer cells feed exclusively on glucose. To capture as much glucose as possible, cancer cells have many insulin receptors—ten times more than any normal cell in the human body. In standard chemotherapy, the chemotherapeutic drugs cannot tell the difference between cancerous cells and normal cells, so they kill them both indiscriminately. But when such drugs are delivered along with insulin, the insulin shuttles them preferentially into the cancer cells. The result of such targeting is the sparing of normal cells and the necessity of a smaller dose of drug to get the job done. "Insulin Potentiation Therapy appears to be a wonderful new way of treating cancer," Dr. Ayre concludes. Circa 2005.
View PDF: Insulin Potentiation Therapy
Subscribe to RSS Feed
